Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenue
Product sales	$ 465,000	$ 197,204	$ 716,250	$ 405,154
Cost of product sales	125,719	59,830	199,704	108,070
Gross profit from product sales	339,281	137,374	516,546	297,084
Other Revenue
Retained royalties	4,647	2,389	13,973	7,037
Other income	30,954	13,673	55,175	39,206
Total other revenue	35,601	16,062	69,148	46,243
Operating expenses
Selling expenses	22,718	67,791	85,537	112,131
Personnel and consulting expenses	444,082	455,087	1,310,139	1,329,466
General and administrative expenses	167,996	362,208	653,940	1,012,369
Total operating expenses	634,796	885,086	2,049,616	2,453,966
Operating loss	(259,914)	(731,650)	(1,463,922)	(2,110,639)
Other expense
Interest expense	393,867	300,361	1,156,797	690,892
Loss on conversion of notes				2,588
Unrealized (gain) loss on derivative instruments	(5,388)	30,791	17,414	41,694
Total other expense	388,479	331,152	1,174,211	735,174
Loss before income taxes	(648,393)	(1,062,802)	(2,638,133)	(2,845,813)
Provision (benefit) for income taxes
Net loss	$ (648,393)	$ (1,062,802)	$ (2,638,133)	$ (2,845,813)
Basic and diluted loss per share (in dollars per share)	$ (0.02)	$ (0.04)	$ (0.09)	$ (0.10)
Basic and diluted weighted average number of common shares outstanding: (in shares)	28,787,831	28,370,953	28,689,254	27,673,151